Delivery Order SPE2DB22D1106-SPE2DB24FEHB7
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The contract, valued at $8,276.19, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order without a set-aside designation, issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to...
- This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,741.62 award is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product. The order has a completion date of February 28, 2024 and was awarded on February 27, 2024. This delivery order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,134.14 firm fixed price delivery order is for Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a specialty pharmaceutical product. The contract has a completion date of March 4, 2024. Amerisourcebergen Drug Corp, as the prime contractor, has received numerous prior awards from DLA Troop Support Medical...
- This federal contract award, valued at $3,674.68, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999, which Amerisourcebergen holds with the DLA Troop Support Medical for delivering a comprehensive range of medical commodities...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $1,741.62 firm fixed price order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $3,374.16 for the supply of Ozempic 0.25-0.5 mg/dose pens. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has a period of performance through March 27, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor....
- This federal contract award to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, is a delivery order valued at $3,867.50 for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 6, 2024. The contract type is Firm Fixed Price, and there was no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and...
- This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply the Defense Logistics Agency (DLA) with a variety of pharmaceutical products and medical supplies. The contract, valued up to $8,391.45, is a firm fixed-price delivery order without a set-aside designation. It is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as...
- This contract award to AmerisourceBergen Drug Corp's Corporate Office division is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999 through December 2025, provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This specific delivery order is for the drug Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, with a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract has a firm fixed price of $4,272.24 and a period of performance through April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this contract. This award is part of a larger...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEHB7Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order valued at $1,161.08 for the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as Amerisourcebergen's primary contract vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities worldwide. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/27/24 |